Heart and Vessels

, Volume 28, Issue 4, pp 497–504 | Cite as

High concentrations of omega-3 fatty acids are associated with the development of atrial fibrillation in the Japanese population

  • Takeshi Tomita
  • Takeki Hata
  • Takahiro Takeuchi
  • Yasutaka Oguchi
  • Ayako Okada
  • Kazunori Aizawa
  • Megumi Koshikawa
  • Kyuhachi Otagiri
  • Hirohiko Motoki
  • Hiroki Kasai
  • Atsushi Izawa
  • Jun Koyama
  • Minoru Hongo
  • Uichi Ikeda
Original Article

Abstract

The favorable effect of fish oils rich in n-3 polyunsaturated fatty acids (PUFAs) on the development of atrial fibrillation (AF) is controversial. The relationship between the serum concentrations of n-3 PUFAs and the incidence of AF is unclear; therefore, in the present study, we aimed to elucidate this relationship. We evaluated the serum concentrations of n-3 PUFAs in 110 patients with AF, 46 patients with ischemic heart disease (IHD) and no AF, and 36 healthy volunteers. Thirty-six patients had a history of IHD (IHD-AF group) and 74 did not (L-AF group). The eicosapentaenoic acid (EPA) levels in the L-AF group were higher than those in the IHD-AF and control groups (117 ± 64, 76 ± 30, and 68 ± 23 μg/ml, respectively); the docosahexaenoic acid (DHA) levels showed the same pattern (170 ± 50, 127 ± 27, and 126 ± 35 μg/ml, respectively). In both the L-AF and IHD-AF groups, the EPA levels in patients with persistent and permanent AF were higher than those in patients with paroxysmal AF (L-AF 131 ± 74 vs. 105 ± 51 μg/ml; IHD-AF 82 ± 28 vs 70 ± 33 μg/ml). Multivariate analysis showed that cases of AF were associated with higher levels of EPA but not DHA. In this Japanese population study, the EPA and DHA levels in patients with L-AF were higher than those in normal subjects. In particular, the EPA level was associated with the incidence of AF. These findings suggest that an excess of EPA might be a precipitating factor of AF.

Keywords

Atrial fibrillation Fatty acids Omega-3 fatty acids Risk factors 

References

  1. 1.
    Kromhout D, Bosschieter EB, de Lezenne Coulander C (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205–1209PubMedCrossRefGoogle Scholar
  2. 2.
    Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2:117–119PubMedCrossRefGoogle Scholar
  3. 3.
    Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D (2005) Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112:2762–2768PubMedCrossRefGoogle Scholar
  4. 4.
    Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113–1118PubMedCrossRefGoogle Scholar
  5. 5.
    Coronel R, Wilms-Schopman FJ, Den Ruijter HM, Belterman CN, Schumacher CA, Opthof T, Hovenier R, Lemmens AG, Terpstra AH, Katan MB, Zock P (2007) Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res 73:386–394PubMedCrossRefGoogle Scholar
  6. 6.
    Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J (2005) Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 293:2884–2891PubMedCrossRefGoogle Scholar
  7. 7.
    Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles MF, Lefkowitz D, Siscovick DS (2004) Fish intake and risk of incident atrial fibrillation. Circulation 110:368–373PubMedCrossRefGoogle Scholar
  8. 8.
    Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M (2005) N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45:1723–1728PubMedCrossRefGoogle Scholar
  9. 9.
    Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC (2006) Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J 151:857–862PubMedCrossRefGoogle Scholar
  10. 10.
    Frost L, Vestergaard P (2005) n-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81:50–54PubMedGoogle Scholar
  11. 11.
    Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM (2010) Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 304:2363–2372PubMedCrossRefGoogle Scholar
  12. 12.
    Saravanan P, Bridgewater B, West AL, O’Neill SC, Calder PC, Davidson NC (2010) Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 3:46–53PubMedCrossRefGoogle Scholar
  13. 13.
    Viviani Anselmi C, Ferreri C, Novelli V, Roncarati R, Bronzini R, Marchese G, Somalvico F, Condorelli G, Montenero AS, Puca AA (2010) Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls. J Interv Card Electrophysiol 27:95–99PubMedCrossRefGoogle Scholar
  14. 14.
    Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP (2009) Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 120:2315–2321PubMedCrossRefGoogle Scholar
  15. 15.
    Sakabe K, Fukuda N, Fukuda Y, Morishita S, Shinohara H, Tamura Y (2010) Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation. Heart Vessels 25:410–416PubMedCrossRefGoogle Scholar
  16. 16.
    Coumel P (1994) Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 15(Suppl A):9–16PubMedCrossRefGoogle Scholar
  17. 17.
    Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, Aruga M, Miyashita T, Yazaki Y, Imamura H, Kinoshita O, Owa M, Kubo K (2003) Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 14:559–564PubMedCrossRefGoogle Scholar
  18. 18.
    Takei M, Furukawa Y, Narita M, Ren LM, Karasawa Y, Murakami M, Chiba S (1991) Synergistic nonuniform shortening of atrial refractory period induced by autonomic stimulation. Am J Physiol 1261(6 Pt 2):H1988–H1993Google Scholar
  19. 19.
    Liu L, Nattel S (1997) Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 273(2 Pt 2):H805–H816PubMedGoogle Scholar
  20. 20.
    Holguin F, Tellez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernandez M, Romieu I (2005) Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127:1102–1107PubMedCrossRefGoogle Scholar
  21. 21.
    Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S (2003) Atrial ischemia promotes atrial fibrillation in dogs. Circulation 107:1930–1936PubMedCrossRefGoogle Scholar
  22. 22.
    Olgin JE, Sih HJ, Hanish S, Jayachandran JV, Wu J, Zheng QH, Winkle W, Mulholland GK, Zipes DP, Hutchins G (1998) Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation 98:2608–2614PubMedCrossRefGoogle Scholar
  23. 23.
    Ravelli F, Allessie M (1997) Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 96:1686–1695PubMedCrossRefGoogle Scholar
  24. 24.
    Rechavia E, Strasberg B, Mager A, Zafrir N, Kusniec J, Sagie A, Sclarovsky S (1992) The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement. Am Heart J 124:387–391PubMedCrossRefGoogle Scholar
  25. 25.
    Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM (2003) Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 108:1461–1468PubMedCrossRefGoogle Scholar
  26. 26.
    Satoh T, Zipes DP (1996) Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol 7:833–842PubMedCrossRefGoogle Scholar
  27. 27.
    Sugiura T, Iwasaka T, Takahashi N, Yuasa F, Takeuchi M, Hasegawa T, Matsutani M, Inada M (1991) Factors associated with atrial fibrillation in Q wave anterior myocardial infarction. Am Heart J 121:1409–1412PubMedCrossRefGoogle Scholar
  28. 28.
    Skuladottir GV, Heidarsdottir R, Arnar DO, Torfason B, Edvardsson V, Gottskalksson G, Palsson R, Indridason OS (2011) Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur J Clin Invest 41:995–1003PubMedCrossRefGoogle Scholar
  29. 29.
    Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455CrossRefGoogle Scholar
  30. 30.
    Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:757–761PubMedCrossRefGoogle Scholar
  31. 31.
    Lavie CJ, Milani RV, Mehra MR, Ventura HO (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54:585–594PubMedCrossRefGoogle Scholar
  32. 32.
    Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369:1090–1098PubMedCrossRefGoogle Scholar
  33. 33.
    Ikeda N, Nakamura M, Yazaki Y, Ono T, Yamamoto M, Ito S, Yokouchi I, Yajima S, Iijima R, Hara H, Takagi T, Asahara T, Sakai H, Sugi K (2010) A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function. Heart Vessels 26:473–479PubMedCrossRefGoogle Scholar
  34. 34.
    Sakabe M, Shiroshita-Takeshita A, Maguy A, Dumesnil C, Nigam A, Leung TK, Nattel S (2007) Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Circulation 116:2101–2109PubMedCrossRefGoogle Scholar
  35. 35.
    Macchia A, Monte S, Pellegrini F, Romero M, Ferrante D, Doval H, D’Ettorre A, Maggioni AP, Tognoni G (2008) Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur J Clin Pharmacol 64:627–634PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2012

Authors and Affiliations

  • Takeshi Tomita
    • 1
  • Takeki Hata
    • 1
  • Takahiro Takeuchi
    • 1
  • Yasutaka Oguchi
    • 1
  • Ayako Okada
    • 1
  • Kazunori Aizawa
    • 1
  • Megumi Koshikawa
    • 1
  • Kyuhachi Otagiri
    • 1
  • Hirohiko Motoki
    • 1
  • Hiroki Kasai
    • 1
  • Atsushi Izawa
    • 1
  • Jun Koyama
    • 1
  • Minoru Hongo
    • 1
  • Uichi Ikeda
    • 1
  1. 1.Department of Cardiovascular MedicineShinshu University School of MedicineMatsumotoJapan

Personalised recommendations